EGFR and colorectal cancer: Ta and colleagues demonstrated that a phosphorylated pro-survival form of the tumor necrosis factor receptor Fas, i.e. Fas.Y291D, enhances EGFR signaling and promotes activation of the nuclear EGF/STAT3 pathway by inducing nuclear accumulation of phospho-EGFR and phospho-STAT3 in colorectal cancer cells.